Cargando…

The Effects of Topiroxostat, a Selective Xanthine Oxidoreductase Inhibitor, on Arterial Stiffness in Hyperuricemic Patients with Liver Dysfunction: A Sub-Analysis of the BEYOND-UA Study

Background: The effects of uric acid (UA)-lowering therapy with xanthine oxidoreductase (XOR) inhibitors on the development of cardiovascular diseases remain controversial. Based on recent findings that plasma XOR activity increased in liver disease conditions, we conducted a sub-analysis of the BEY...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujishima, Yuya, Nishizawa, Hitoshi, Kawachi, Yusuke, Nakamura, Takashi, Akari, Seigo, Ono, Yoshiyuki, Fukuda, Shiro, Kita, Shunbun, Maeda, Norikazu, Hoshide, Satoshi, Shimomura, Iichiro, Kario, Kazuomi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045538/ https://www.ncbi.nlm.nih.gov/pubmed/36979653 http://dx.doi.org/10.3390/biomedicines11030674

Ejemplares similares

Plasma xanthine oxidoreductase activity in Japanese patients with type 2 diabetes across hospitalized treatment
por: Kawachi, Yusuke, et al.
Publicado: (2020)

Influence of xanthine oxidoreductase inhibitor, topiroxostat, on body weight of diabetic obese mice
por: Nakamura, Takashi, et al.
Publicado: (2021)

Increased plasma XOR activity induced by NAFLD/NASH and its possible involvement in vascular neointimal proliferation
por: Kawachi, Yusuke, et al.
Publicado: (2021)

Time-Series Change of Serum Soluble T-Cadherin Concentrations and Its Association with Creatine Kinase-MB Levels in ST-Segment Elevation Myocardial Infarction
por: Iioka, Masahito, et al.
Publicado: (2022)

Long-Term Safety and Effectiveness of the Xanthine Oxidoreductase Inhibitor, Topiroxostat in Japanese Hyperuricemic Patients with or Without Gout: A 54-week Open-label, Multicenter, Post-marketing Observational Study
por: Ishikawa, Tomohiko, et al.
Publicado: (2020)

Renoprotective Effect of Xanthine Oxidase Inhibitor, Topiroxostat
por: Katsuyama, Hisayuki, et al.
Publicado: (2019)

Comparative effects of topiroxostat and febuxostat on arterial properties in hypertensive patients with hyperuricemia
por: Kario, Kazuomi, et al.
Publicado: (2021)

Native adiponectin in serum binds to mammalian cells expressing T-cadherin, but not AdipoRs or calreticulin
por: Kita, Shunbun, et al.
Publicado: (2019)

Identification and Clinical Associations of 3 Forms of Circulating T-cadherin in Human Serum
por: Fukuda, Shiro, et al.
Publicado: (2021)

Adiponectin accumulation in the retinal vascular endothelium and its possible role in preventing early diabetic microvascular damage
por: Sakaue, Taka-aki, et al.
Publicado: (2022)

Orange Juice and Hesperetin Supplementation to Hyperuricemic Rats Alter Oxidative Stress Markers and Xanthine Oxidoreductase Activity
por: Haidari, Fatemeh, et al.
Publicado: (2009)

ER stress decreases exosome production through adiponectin/T-cadherin-dependent and -independent pathways
por: Fukuoka, Keita, et al.
Publicado: (2023)

Soluble T-cadherin promotes pancreatic β-cell proliferation by upregulating Notch signaling
por: Okita, Tomonori, et al.
Publicado: (2022)

Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockade
por: Kawada-Horitani, Emi, et al.
Publicado: (2022)

Adiponectin Stimulates Exosome Release to Enhance Mesenchymal Stem-Cell-Driven Therapy of Heart Failure in Mice
por: Nakamura, Yuto, et al.
Publicado: (2020)

Randomized control trial for the assessment of the anti-albuminuric effects of topiroxostat in hyperuricemic patients with diabetic nephropathy (the ETUDE study)
por: Kato, Sawako, et al.
Publicado: (2016)

Extracellular Vesicles as an Endocrine Mechanism Connecting Distant Cells
por: Kita, Shunbun, et al.
Publicado: (2022)

Impact of visceral fat on gene expression profile in peripheral blood cells in obese Japanese subjects
por: Obata, Yoshinari, et al.
Publicado: (2016)

Gypenosides Inhibits Xanthine Oxidoreductase and Ameliorates Urate Excretion in Hyperuricemic Rats Induced by High Cholesterol and High Fat Food (Lipid Emulsion)
por: Pang, Minxia, et al.
Publicado: (2017)

Multicenter, Open-Label Study of Long-Term Topiroxostat (FYX-051) Administration in Japanese Hyperuricemic Patients with or Without Gout
por: Hosoya, Tatsuo, et al.
Publicado: (2018)

Low muscle quality in Japanese type 2 diabetic patients with visceral fat accumulation
por: Murai, Jun, et al.
Publicado: (2018)

Multiple Gouty Tophi with Bone Erosion and Destruction: A Report of an Early-onset Case in an Obese Patient
por: D Hayashi, Reiko, et al.
Publicado: (2017)

Adiponectin promotes muscle regeneration through binding to T-cadherin
por: Tanaka, Yoshimitsu, et al.
Publicado: (2019)

Author Correction: Adiponectin promotes muscle regeneration through binding to T-cadherin
por: Tanaka, Yoshimitsu, et al.
Publicado: (2020)

Clinical Effects of Topiroxostat on Renal and Endothelial Function in A Patient with Chronic Kidney Disease and Hyperuricemic Arteriolopathy: A Case Report
por: Tanaka, Atsushi, et al.
Publicado: (2017)

Favine/CCDC3 deficiency accelerated atherosclerosis and thrombus formation is associated with decreased MEF2C-KLF2 pathway
por: Kobayashi, Sachiko, et al.
Publicado: (2022)

Possible role of insulin resistance in activation of plasma xanthine oxidoreductase in health check-up examinees
por: Kurajoh, Masafumi, et al.
Publicado: (2022)

Effects of topiroxostat on the serum urate levels and urinary albumin excretion in hyperuricemic stage 3 chronic kidney disease patients with or without gout
por: Hosoya, Tatsuo, et al.
Publicado: (2014)

Systemic Endothelial Function, Plasma Xanthine Oxidoreductase Activity, and Blood Pressure Variability in Patients with Stable Coronary Artery Disease
por: Hiraga, Takashi, et al.
Publicado: (2022)

Long-term impact of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight and glycemic control in Japanese type 2 diabetes: an observational study
por: Inoue, Kana, et al.
Publicado: (2014)

Clinical efficacy and safety of topiroxostat in Japanese hyperuricemic patients with or without gout: a randomized, double-blinded, controlled phase 2b study
por: Hosoya, Tatsuo, et al.
Publicado: (2016)

Pro-Aging Effects of Xanthine Oxidoreductase Products
por: Battelli, Maria Giulia, et al.
Publicado: (2020)

Xanthine oxidoreductase activity is correlated with hepatic steatosis
por: Yagi, Chisako, et al.
Publicado: (2022)

Discriminating Susceptibility of Xanthine Oxidoreductase Family to Metals
por: Steunou, Anne-Soisig, et al.
Publicado: (2023)

Identification of Mouse Mesenteric and Subcutaneous in vitro Adipogenic Cells
por: Miyata, Yugo, et al.
Publicado: (2016)

Association between plasma xanthine oxidoreductase activity and in-hospital outcomes in patients with stable coronary artery disease after percutaneous coronary intervention
por: Sato, Ryota, et al.
Publicado: (2021)

Associations of circulating xanthine oxidoreductase activity with cardiometabolic risk markers in overweight and obese Japanese men: a cross-sectional pilot study
por: Kosaki, Keisei, et al.
Publicado: (2022)

Metabolic syndrome and cancer risk: The role of xanthine oxidoreductase
por: Battelli, Maria Giulia, et al.
Publicado: (2018)

Xanthine oxidoreductase: One enzyme for multiple physiological tasks
por: Bortolotti, Massimo, et al.
Publicado: (2021)

Evaluation of Neuronal Protective Effects of Xanthine Oxidoreductase Inhibitors on Severe Whole-brain Ischemia in Mouse Model and Analysis of Xanthine Oxidoreductase Activity in the Mouse Brain
por: SUZUKI, Go, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_k77rg29gfn6kvs0rbvc9brivj7